Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome

Autores
Cobeñas, Carlos J.; Bresso, Paula; Lombardi, Laura L.; Amoreo, Oscar; Ruscasso, Javier D.; Spizzirri, Ana P.; Suarez, Ângela del C.; Zalba, Javier; Rahman, Ricardo C.; Risso, Paula
Año de publicación
2015
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
We performed a retrospective evaluation of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with the aims of: (1) determining the rate of red blood cell (RBC) transfusions; (2) establishing the relationship between need for RBC transfusion and severity of renal involvement; (3) determining whether precise measurements of lactic dehydrogenase (LDH) levels can predict the rate of hemolysis and severity of renal disease. A total of 288 patients with D + HUS were retrospectively divided into three groups based on dialysis treatment: group 1, no dialysis treatment (144 patients); group 2, dialysis for 1–10 days (67 patients); group 3, dialysis for ≥11 days (77 patients). Of the patients in groups 1, 2 and 3, 73.6, 86.5 and 83.1 %, respectively, required at least one RBC transfusion. The number of RBC transfusions in groups 1, 2 and 3 was 163, 107 and 162, respectively. Comparison of the groups revealed that the number of RBC transfusions was significantly higher in patients in groups 2 and 3 than in those in group 1 (p = 0.0001). Most RBC transfusions (94.2 %) occurred during the first 2 weeks of the disease. The median peak LDH level was 2091 U/l in 32 patients with no RBC transfusion (group A), 3900 U/l in 73 patients with one transfusion (group B) and 6378 U/l in 62 patients with two or more transfusions (group C). Patients who received two or more RBC transfusions had a significantly higher median peak LDH level than those who did not receive RBC transfusions or received only one transfusion. This difference was also observed between patients who received only one RBC transfusion and those who did not receive any transfusions (p  10 days of dialysis (group 3) had the highest LDH levels, followed by patients with 1–10 days of dialysis (group 2) and then by patients with no dialysis requirements (group 1) (p < 0.00001). The rate of RBC transfusion was higher in patients with the most severe renal injury, and most were performed during the first 2 weeks of the disease. Patients with stable LDH levels seemed to require fewer RBC transfusions. Median peak LDH levels were significantly higher in the group of patients with the most severe renal disease.
Facultad de Ciencias Veterinarias
Materia
Bioquímica
Hemolytic uremic syndrome
Microangiopathic hemolytic anemia
Red blood cell transfusions
Lactic dehydrogenase levels
Renal disease
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/136322

id SEDICI_9973036df6d8c8bcdfee9bf71a05c13f
oai_identifier_str oai:sedici.unlp.edu.ar:10915/136322
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndromeCobeñas, Carlos J.Bresso, PaulaLombardi, Laura L.Amoreo, OscarRuscasso, Javier D.Spizzirri, Ana P.Suarez, Ângela del C.Zalba, JavierRahman, Ricardo C.Risso, PaulaBioquímicaHemolytic uremic syndromeMicroangiopathic hemolytic anemiaRed blood cell transfusionsLactic dehydrogenase levelsRenal diseaseWe performed a retrospective evaluation of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with the aims of: (1) determining the rate of red blood cell (RBC) transfusions; (2) establishing the relationship between need for RBC transfusion and severity of renal involvement; (3) determining whether precise measurements of lactic dehydrogenase (LDH) levels can predict the rate of hemolysis and severity of renal disease. A total of 288 patients with D + HUS were retrospectively divided into three groups based on dialysis treatment: group 1, no dialysis treatment (144 patients); group 2, dialysis for 1–10 days (67 patients); group 3, dialysis for ≥11 days (77 patients). Of the patients in groups 1, 2 and 3, 73.6, 86.5 and 83.1 %, respectively, required at least one RBC transfusion. The number of RBC transfusions in groups 1, 2 and 3 was 163, 107 and 162, respectively. Comparison of the groups revealed that the number of RBC transfusions was significantly higher in patients in groups 2 and 3 than in those in group 1 (p = 0.0001). Most RBC transfusions (94.2 %) occurred during the first 2 weeks of the disease. The median peak LDH level was 2091 U/l in 32 patients with no RBC transfusion (group A), 3900 U/l in 73 patients with one transfusion (group B) and 6378 U/l in 62 patients with two or more transfusions (group C). Patients who received two or more RBC transfusions had a significantly higher median peak LDH level than those who did not receive RBC transfusions or received only one transfusion. This difference was also observed between patients who received only one RBC transfusion and those who did not receive any transfusions (p  10 days of dialysis (group 3) had the highest LDH levels, followed by patients with 1–10 days of dialysis (group 2) and then by patients with no dialysis requirements (group 1) (p < 0.00001). The rate of RBC transfusion was higher in patients with the most severe renal injury, and most were performed during the first 2 weeks of the disease. Patients with stable LDH levels seemed to require fewer RBC transfusions. Median peak LDH levels were significantly higher in the group of patients with the most severe renal disease.Facultad de Ciencias Veterinarias2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf2115-2119http://sedici.unlp.edu.ar/handle/10915/136322enginfo:eu-repo/semantics/altIdentifier/issn/1432-198Xinfo:eu-repo/semantics/altIdentifier/issn/0931-041Xinfo:eu-repo/semantics/altIdentifier/doi/10.1007/s00467-015-3147-xinfo:eu-repo/semantics/altIdentifier/pmid/26141929info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-03T11:04:28Zoai:sedici.unlp.edu.ar:10915/136322Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-03 11:04:28.413SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
title Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
spellingShingle Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
Cobeñas, Carlos J.
Bioquímica
Hemolytic uremic syndrome
Microangiopathic hemolytic anemia
Red blood cell transfusions
Lactic dehydrogenase levels
Renal disease
title_short Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
title_full Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
title_fullStr Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
title_full_unstemmed Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
title_sort Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome
dc.creator.none.fl_str_mv Cobeñas, Carlos J.
Bresso, Paula
Lombardi, Laura L.
Amoreo, Oscar
Ruscasso, Javier D.
Spizzirri, Ana P.
Suarez, Ângela del C.
Zalba, Javier
Rahman, Ricardo C.
Risso, Paula
author Cobeñas, Carlos J.
author_facet Cobeñas, Carlos J.
Bresso, Paula
Lombardi, Laura L.
Amoreo, Oscar
Ruscasso, Javier D.
Spizzirri, Ana P.
Suarez, Ângela del C.
Zalba, Javier
Rahman, Ricardo C.
Risso, Paula
author_role author
author2 Bresso, Paula
Lombardi, Laura L.
Amoreo, Oscar
Ruscasso, Javier D.
Spizzirri, Ana P.
Suarez, Ângela del C.
Zalba, Javier
Rahman, Ricardo C.
Risso, Paula
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Bioquímica
Hemolytic uremic syndrome
Microangiopathic hemolytic anemia
Red blood cell transfusions
Lactic dehydrogenase levels
Renal disease
topic Bioquímica
Hemolytic uremic syndrome
Microangiopathic hemolytic anemia
Red blood cell transfusions
Lactic dehydrogenase levels
Renal disease
dc.description.none.fl_txt_mv We performed a retrospective evaluation of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with the aims of: (1) determining the rate of red blood cell (RBC) transfusions; (2) establishing the relationship between need for RBC transfusion and severity of renal involvement; (3) determining whether precise measurements of lactic dehydrogenase (LDH) levels can predict the rate of hemolysis and severity of renal disease. A total of 288 patients with D + HUS were retrospectively divided into three groups based on dialysis treatment: group 1, no dialysis treatment (144 patients); group 2, dialysis for 1–10 days (67 patients); group 3, dialysis for ≥11 days (77 patients). Of the patients in groups 1, 2 and 3, 73.6, 86.5 and 83.1 %, respectively, required at least one RBC transfusion. The number of RBC transfusions in groups 1, 2 and 3 was 163, 107 and 162, respectively. Comparison of the groups revealed that the number of RBC transfusions was significantly higher in patients in groups 2 and 3 than in those in group 1 (p = 0.0001). Most RBC transfusions (94.2 %) occurred during the first 2 weeks of the disease. The median peak LDH level was 2091 U/l in 32 patients with no RBC transfusion (group A), 3900 U/l in 73 patients with one transfusion (group B) and 6378 U/l in 62 patients with two or more transfusions (group C). Patients who received two or more RBC transfusions had a significantly higher median peak LDH level than those who did not receive RBC transfusions or received only one transfusion. This difference was also observed between patients who received only one RBC transfusion and those who did not receive any transfusions (p  10 days of dialysis (group 3) had the highest LDH levels, followed by patients with 1–10 days of dialysis (group 2) and then by patients with no dialysis requirements (group 1) (p < 0.00001). The rate of RBC transfusion was higher in patients with the most severe renal injury, and most were performed during the first 2 weeks of the disease. Patients with stable LDH levels seemed to require fewer RBC transfusions. Median peak LDH levels were significantly higher in the group of patients with the most severe renal disease.
Facultad de Ciencias Veterinarias
description We performed a retrospective evaluation of patients with diarrhea-associated hemolytic uremic syndrome (D + HUS) with the aims of: (1) determining the rate of red blood cell (RBC) transfusions; (2) establishing the relationship between need for RBC transfusion and severity of renal involvement; (3) determining whether precise measurements of lactic dehydrogenase (LDH) levels can predict the rate of hemolysis and severity of renal disease. A total of 288 patients with D + HUS were retrospectively divided into three groups based on dialysis treatment: group 1, no dialysis treatment (144 patients); group 2, dialysis for 1–10 days (67 patients); group 3, dialysis for ≥11 days (77 patients). Of the patients in groups 1, 2 and 3, 73.6, 86.5 and 83.1 %, respectively, required at least one RBC transfusion. The number of RBC transfusions in groups 1, 2 and 3 was 163, 107 and 162, respectively. Comparison of the groups revealed that the number of RBC transfusions was significantly higher in patients in groups 2 and 3 than in those in group 1 (p = 0.0001). Most RBC transfusions (94.2 %) occurred during the first 2 weeks of the disease. The median peak LDH level was 2091 U/l in 32 patients with no RBC transfusion (group A), 3900 U/l in 73 patients with one transfusion (group B) and 6378 U/l in 62 patients with two or more transfusions (group C). Patients who received two or more RBC transfusions had a significantly higher median peak LDH level than those who did not receive RBC transfusions or received only one transfusion. This difference was also observed between patients who received only one RBC transfusion and those who did not receive any transfusions (p  10 days of dialysis (group 3) had the highest LDH levels, followed by patients with 1–10 days of dialysis (group 2) and then by patients with no dialysis requirements (group 1) (p < 0.00001). The rate of RBC transfusion was higher in patients with the most severe renal injury, and most were performed during the first 2 weeks of the disease. Patients with stable LDH levels seemed to require fewer RBC transfusions. Median peak LDH levels were significantly higher in the group of patients with the most severe renal disease.
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/136322
url http://sedici.unlp.edu.ar/handle/10915/136322
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1432-198X
info:eu-repo/semantics/altIdentifier/issn/0931-041X
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00467-015-3147-x
info:eu-repo/semantics/altIdentifier/pmid/26141929
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
2115-2119
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1842260543340019712
score 13.13397